Rebuttal to the letter 'Meta-analysis of biodegradable versus durable polymer drug eluting stents in coronary artery disease: the reality?' of Kwong et al
- PMID: 23928566
- DOI: 10.1177/2047487313501238
Rebuttal to the letter 'Meta-analysis of biodegradable versus durable polymer drug eluting stents in coronary artery disease: the reality?' of Kwong et al
Comment on
-
Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients.Eur J Prev Cardiol. 2014 Apr;21(4):411-24. doi: 10.1177/2047487312467745. Epub 2012 Nov 14. Eur J Prev Cardiol. 2014. PMID: 23152364 Review.
-
Meta-analysis of biodegradable versus durable polymer drug eluting stents in coronary artery disease: the reality?Eur J Prev Cardiol. 2013 Dec;20(6):1031-2. doi: 10.1177/2047487313501237. Epub 2013 Aug 22. Eur J Prev Cardiol. 2013. PMID: 23970070 No abstract available.
Similar articles
-
Meta-analysis of biodegradable versus durable polymer drug eluting stents in coronary artery disease: the reality?Eur J Prev Cardiol. 2013 Dec;20(6):1031-2. doi: 10.1177/2047487313501237. Epub 2013 Aug 22. Eur J Prev Cardiol. 2013. PMID: 23970070 No abstract available.
-
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011. JACC Cardiovasc Interv. 2013. PMID: 23968698 Clinical Trial.
-
Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264. doi: 10.1016/j.jcin.2016.11.007. Epub 2017 Jan 18. JACC Cardiovasc Interv. 2017. PMID: 28109874 Clinical Trial.
-
Biodegradable versus durable polymer drug eluting stents in coronary artery disease: insights from a meta-analysis of 5,834 patients.Eur J Prev Cardiol. 2014 Apr;21(4):411-24. doi: 10.1177/2047487312467745. Epub 2012 Nov 14. Eur J Prev Cardiol. 2014. PMID: 23152364 Review.
-
Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.Catheter Cardiovasc Interv. 2014 May 1;83(6):E193-206. doi: 10.1002/ccd.25416. Epub 2014 Feb 10. Catheter Cardiovasc Interv. 2014. PMID: 24478247 Review.
Cited by
-
A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease.Biologics. 2013;7:149-59. doi: 10.2147/BTT.S34939. Epub 2013 Jun 19. Biologics. 2013. PMID: 23818756 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical